Executive Director, Theranostics Platform Enablement

Novartis•East Hanover, NJ

4d•$236,600 - $439,400

About The Position

The Executive Director, Theranostics Platform Enablement is accountable for shaping and aligning cross-functional strategies that sustain and expand Novartis’s Theranostics leadership. The role strengthens platform capabilities supporting current Radioligand Therapy (RLT) leadership and future Radioligand Imaging (RLI)-supported growth, including patient identification, site readiness, access, referral flow, treatment capacity, and analytics-driven decision making. Working across the Theranostics ecosystem, this leader aligns priorities, guides strategic workstreams, and addresses barriers that prevent eligible patients from being identified, referred, accessing, and receiving appropriate RLT medicines. The role collaborates closely with the Integrated Product Strategy team, RLT and RLI general management teams, and stakeholders across Commercial, Medical, Market Access, Patient Services, Legal, Operations, Finance, and Strategy. It uses analytics, account insights, and ecosystem trends to identify bottlenecks, prioritize interventions, inform senior leadership decisions, and support therapeutic-area resource allocation. The position oversees a budget of up to $40 million for cross-functional initiatives and leads and develops two Associate Directors (one current and one planned for 2027), while influencing matrixed teams to deliver against therapeutic-area priorities.

Requirements

Bachelor’s degree required.
10 or more years of relevant experience in pharmaceutical marketing or P&L, consulting, investment banking, legal, or another relevant field.
Demonstrated ability to lead large-scale, cross-functional initiatives across Oncology, RLT, diagnostics, imaging, platform enablement, market access, patient services, analytics, or strategy.
Experience translating complex data, customer insights, and ecosystem dynamics into executive-level decisions and prioritized actions.
Proven ability to operate with ambiguity, urgency, and senior stakeholder visibility while driving alignment across matrixed teams.
Experience managing budgets, leading teams, and delivering high-impact initiatives with measurable business outcomes.

Nice To Haves

Advanced degree preferred.
Radiopharmaceutical, RLT, RLI, diagnostics, imaging, or advanced therapeutic platform experience preferred.

Responsibilities

Own and advance therapeutic-area-critical Theranostics platform enablement strategies that support current RLT leadership, strengthen readiness for future RLI-supported growth, and accelerate commercial ambition.
Collaborate with and influence Commercial Execution, New Product Strategy, Marketing, Market Access, Patient Services, Medical, Legal, Operations, Finance, and Strategy to improve patient identification, referral flow, site readiness, treatment access, and customer experience.
Translate analytics, account insights, and ecosystem trends into prioritized actions addressing bottlenecks across RLT and RLI pathways.
Drive therapeutic-area prioritization, investment trade-off discussions, and resource alignment for Theranostics platform enablement with senior leadership and cross-functional governance forums.
Drive alignment and progress across high-priority strategic workstreams with senior stakeholder visibility, including treatment site access, capacity, patient flow, and launch readiness.
Oversee a budget of up to $40 million dedicated to cross-functional Theranostics platform enablement initiatives.
Lead and develop two Associate Directors, including one current position and one planned for 2027, and influence matrixed teams to deliver against therapeutic-area priorities.